Navigation Links
Sensus Healthcare Announces Strategic Partnership With Flagship Solutions Group
Date:1/24/2011

BOCA RATON, Fla., Jan. 24, 2011 /PRNewswire/ -- Sensus Healthcare has entered into a strategic partnership with Flagship Solutions Group in an effort to merge joint interests in IT solutions for the medical field and meet the underserved needs of the dermatology and oncology practices in the United States and the global arena. As an IBM Premier Business Partner and a certified IBM Dynamic Infrastructure Partner, Flagship has attained a prestigious status which fewer than five percent of all IBM Business Partners are able to reach in less than two years. Sensus is teaming with Flagship in providing world-class IBM solutions, products, and services to its customers.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO)

"The dynamics of this partnership will have far reaching effects that will provide our customers with unprecedented advantages in the operations of their medical practices in the areas of increased productivity and lower costs." – Joe Sardano (Chief Executive Officer, Sensus Healthcare)

"I am thrilled to work with Sensus Healthcare.  Together we have the ability to provide the medical field with cutting edge technology services that will make it easier and more cost efficient for them to manage and grow their business. " – Mark Wyllie (Chief Executive Officer, Flagship Solutions Group)

Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated low-dose superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician SRT-100&#
'/>"/>

SOURCE Sensus Healthcare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. New consensus on work-related asthma
2. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
3. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
4. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
5. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
6. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
7. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
8. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
9. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
11. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  Personal Genome Diagnostics Inc. (PGDx), ... methodologies and expertise in genomic analysis of defined ... collaboration with Blueprint Medicines.  PGDx is an innovator ... alterations in tumors, and Blueprint Medicines is an ... a genetically defined patient population. "This ...
(Date:5/21/2013)... Ontario (PRWEB) May 21, 2013 ... scientists of the ITN to design the study, ... of two key clinical models used in the ... (EEC) and Nasal Allergen Challenge (NAC) models. Although ... by numerous publications, to date no direct comparison ...
(Date:5/21/2013)... PathoGenetix, Inc., a commercial-stage developer of ... today that it has successfully identified and strain typed ... from the Centers for Disease Control and Prevention (CDC) ... findings are detailed in a poster presented ... Microbiology in Denver on Monday. , The 250 E. ...
(Date:5/20/2013)... UAE (PRWEB) May 21, 2013 ... consultancy specializing in “game-changing” life science and health related ... Dalia Dergham to its International Project Team. Dergham's expertise ... even greater multi-cultural depth to Grace Century as it ... the globe. , Ms. Dergham holds both an under ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
... TORONTO, ON - Quantum mechanics is famous for saying that ... there doesn,t make a sound. Quantum mechanics also says that ... tree. And so the famous paradox: how can we ... An international team of researchers, led by University ...
... Genentech and Novartis have the best image among ... market research consultancy that recently completed its 2011 MSImage ... corporate equity and R&D attributes to determine which measures ... growing marketplace. Amgen, Sanofi-aventis and Eli ...
... 2, 2011 Morphotek®, Inc., a subsidiary of Eisai ... phase II study of MORAb-004 for the treatment of ... first-in-class monoclonal antibody that specifically binds to endosialin/tumor endothelial ... safety and therapeutic activity at two dosages. ...
Cached Biology Technology:U of T scientist leads international team in quantum physics first 2U of T scientist leads international team in quantum physics first 3Genentech and Novartis Remain Image Leaders in Oncology and Hematology 2Genentech and Novartis Remain Image Leaders in Oncology and Hematology 3Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 3
(Date:5/21/2013)... Widely available in pharmacies and health stores, phosphatidylserine ... oysters, and soy. Proven to improve cognition and ... older people experiencing memory impairment. Now a team ... Bochner of Tel Aviv University,s Department of ... same supplement improves the functioning of genes involved ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
(Date:5/20/2013)... Minnesota Medical School researchers from the Masonic Cancer Center, ... Tumor Program, have developed a new mouse model of ... to discover new genes and gene pathways driving this ... week in the journal Nature Genetics . , ... lab of David Largaespada, Ph.D., professor in the Medical ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4U of M researchers develop model for better testing, targeting of MPNST 2
... combined with an immune-boosting substance called an adjuvant, ... strain of avian influenza (H9N2) provoked a strong ... by the National Institute of Allergy and Infectious ... Health. , The clinical trial of 96 adults ...
... brain cells on a new three-dimensional scaffold of tiny ... body than any other cell culture system. , An ... may one day replace the ubiquitous Petri dish for ... ONE. Shuguang Zhang, associate director of MIT's Center for ...
... Peering deep within the cells of fruit flies, developmental ... University in Philadelphia may have discovered a new way ... If they're right, and the same processes are at ... eventually have implications for improving the understanding of a ...
Cached Biology News:H9N2 avian flu vaccine paired with adjuvant provokes strong human immune response at low doses 2MIT creates 3-D scaffold for growing stem cells 2MIT creates 3-D scaffold for growing stem cells 3Jefferson researchers uncover new way nature turns genes on and off 2
...
...
... 48° Fixed Angle Polypropylene Rotor ... Series, IEC Centra CL3/CL3R** and Centra-MP4/MP4R*. ... quiet operation. /MP4, ,EXCLUSIVE polypropylene rotor ... can be repeatedly autoclaved. Polypropylene ...
The 891 45° Fixed Angle Rotor is designed to provide aerosol containment and can be removed from a centrifuge (seal entact) and opened under an environmental hood....
Biology Products: